Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Anemia And Other Blood Disorder Drugs Market Expected To Grow In Terms Of Size?

Over the past few years, the market size for drugs treating anemia and other blood disorders has seen robust growth. It is projected to expand from $11.81 billion in 2024 to $12.46 billion in 2025, representing a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the historical period include the prevalence of the disease, global health campaigns, an aging population, innovation in the pharmaceutical sector, and increased patient awareness.

The market for drugs treating anemia and other blood disorders is projected to experience a robust increase in the coming years. It is predicted to reach a value of “$15.82 billion in 2029, with a compound annual growth rate (CAGR) of 6.1%. This projected growth within the forecast period is largely due to the influence of emerging markets, worldwide demographic changes, and economic conditions. Notable trends for the forecast period encompass advancements in research and development, technological innovation, biologics and specialized therapies, gene therapy initiatives, developments in telemedicine and remote monitoring, the designation of orphan drugs, and the occurrence of mergers and acquisitions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp

Which Industry Forces Are Driving The Anemia And Other Blood Disorder Drugs Market Forward?

The rise in the occurrence of anemia across the global populace is a substantial factor propelling the market. Deteriorating health practices, evolving eating habits, and heightened stress have resulted in elevated instances of anemia globally. For example, anemia has emerged as the most common ailment among the elderly group (above 65 years), attaining a prevalence rate of approximately 17%. The World Bank disclosed that anemia ranks as the 8th leading illness among women and younger individuals. This surge in the prevalence of anemia acts as a catalyst for the anemia and other blood disorder drugs market.

Which Segmentation Categories Are Highlighted In The Anemia And Other Blood Disorder Drugs Market Analysis?

The anemia and other blood disorder drugs market covered in this report is segmented –

1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia

2) By Route of Administration: Oral, Injectable

3) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy

Subsegments:

1) By Iron Deficiency Anemia: Oral Iron Supplements, Injectable Iron Supplements, Iron Fortified Foods

2) By Chronic Kidney Disease Anemia: Erythropoiesis-Stimulating Agents (ESAs), Iron Supplements, Blood Transfusion

3) By Sickle Cell Anemia: Hydroxyurea, Blood Transfusions, Gene Therapy, Pain Management Drugs

4) By Aplastic Anemia: Immunosuppressive Therapy, Stem Cell Transplantation, Erythropoiesis-Stimulating Agents (ESAs)

Which Market Trends Are Expected To Define The Future Of The Anemia And Other Blood Disorder Drugs Market?

Companies operating in the market for anemia and other blood disorder drugs are forging partnerships with government bodies to develop and bring to market specific types of drugs, sharing expertise, technology, and costs. These partnerships prove beneficial for these firms in the event of license expiry and tight regulatory controls. Disc Medicine, for instance, announced in March 2023 that it would be working in collaboration with the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) on the Phase 1/2 and Phase 2 clinical trials of biopterin to treat Diamond-Blackfan Anemia (DBA) patients and adults with iron deficiency anemia. The NIH will fund and conduct these trials under a cooperative research and development agreement (CRADA).

Who Are The Dominant Players In The Anemia And Other Blood Disorder Drugs Market Today?

Major companies operating in the anemia and other blood disorder drugs market include Amgen Inc, GlaxoSmithKline plc, Akebia Therapeutics Inc., Bayer AG, Pfizer Inc, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Global Blood Therapeutics Inc., GlycoMimetics Inc., Eli Lilly and Company, FibroGen Inc., bluebird bio Inc., Acceleron Pharma Inc., AMAG Pharmaceuticals Inc., Pieris Pharmaceuticals Inc., Vifor Pharma Management Ltd., Sanofi S.A., Allergan U.S. Inc., Meda Consumer Healthcare Inc., AbbVie Inc., Johnson & Johnson, Daiichi Sankyo Company Limited, Galenica Ltd., Pharmacosmos A/S, Emmaus Medical Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Merck & Co. Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., uniQure N.V., Rubius Therapeutics Inc., BioMarin Pharmaceutical Inc., Grifols S.A., Orchard Therapeutics plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Anemia And Other Blood Disorder Drugs Market?

North America was the largest region in the anemia and other blood disorder drugs market in 2024. Middle East is expected to be the fastest-growing region in the anemia and other blood disorder drugs market during the forecast period. The regions covered in the anemia and other blood disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2465&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model